CN107115356A - A kind of dermatological field antiseptic - Google Patents
A kind of dermatological field antiseptic Download PDFInfo
- Publication number
- CN107115356A CN107115356A CN201710381475.3A CN201710381475A CN107115356A CN 107115356 A CN107115356 A CN 107115356A CN 201710381475 A CN201710381475 A CN 201710381475A CN 107115356 A CN107115356 A CN 107115356A
- Authority
- CN
- China
- Prior art keywords
- parts
- antiseptic
- surfactant
- chitin
- dermatological field
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/77—Polymers containing oxygen of oxiranes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a kind of dermatological field antiseptic, including hydrogen peroxide, ethanol, Cocoamidopropyl betaine, algal polysaccharides, chitin, polyethoxyolefin carboxyl guanidine, surfactant, the mass fraction of each component is：25 parts of hydrogen peroxide, 2 3.8 parts of ethanol, 1.8 3 parts of Cocoamidopropyl betaine, 1.5 2.5 parts of algal polysaccharides, 2 2.5 parts of chitin, 2 2.5 parts of polyethoxyolefin carboxyl guanidine, 1.5 3 parts of surfactant.This antiseptic has the advantages that stability is good, usage amount is low, antibacterial bacterium composes wide, high-efficiency antimicrobial, the antibacterial effect duration is long, is widely used in various daily life fields and medical domain.
Description
Technical field
The present invention relates to a kind of antiseptic.Especially, the present invention relates to a kind of antimicrobial, antibacterial, antimycotic, antiviral
Dermatological field antiseptic.
Background technology
At present, clinical when treating various infective wound surfaces, the conventional treatments used are antibacterial, anti-inflammatory, debridement.
External used medicine used is generally antibiosis anti-inflammatory drug over the course for the treatment of.But there is certain weak point in these medicines.Such as clinic
The antibiotic medicines such as upper conventional tetracycline ointment, gentamicin sliver, nitrofurazone sliver, as its is extensive and heavy dose of
Using, sensitive bacteria is produced the corresponding resistance to the action of a drug to it, therefore unsatisfactory curative effect, along with antibiotics only has antibacterial action,
The blood circulation of local organization can not be promoted and suppress oozing out for wound fluid, so, once there is the resistance to the action of a drug in bacterium, wound
The infection in face can further deteriorate, so as to cause the disastrous effect of protracted course of disease.Though bacterium is not likely to produce the resistance to the action of a drug in the treatment,
The effect of its antibacterial and anti-inflammation functions and promotion organization healing is weaker, therefore the healing stage of wound is longer.Although natural prodcuts are pacified
Entirely, it is but general expensive, there is no biocidal effect to broad-spectrum biological body such as Gram-negative and gram-positive bacterium and fungi.
The content of the invention
For above shortcomings in the prior art, it is good that the technical problems to be solved by the invention are to provide a kind of effect
Dermatological field antiseptic.
The technical solution adopted for the present invention to solve the technical problems is：A kind of dermatological field antiseptic is provided,
Including hydrogen peroxide, ethanol, Cocoamidopropyl betaine, algal polysaccharides, chitin, polyethoxyolefin carboxyl guanidine, surface-active
Agent, the mass fraction of each component is：2-5 parts of hydrogen peroxide, 2-3.8 parts of ethanol, 1.8-3 parts of Cocoamidopropyl betaine, sea
1.5-2.5 parts of polysaccharides, 2-2.5 parts of chitin, 2-2.5 parts of polyethoxyolefin carboxyl guanidine, 1.5-3 parts of surfactant.
Preferably, described dermatological field antiseptic, the mass fraction of each component is：2 parts of hydrogen peroxide, second
2 parts of alcohol, 1.8 parts of Cocoamidopropyl betaine, 1.5 parts of algal polysaccharides, 2 parts of chitin, 2 parts of polyethoxyolefin carboxyl guanidine, surface
1.5 parts of activating agent.
Preferably, described dermatological field antiseptic, the surfactant is sulfonate, sulfate surface
Activating agent, phosphonate surfactant, phosphate surfactant active, the husky nurse of pool network, cationic surfactant or its mixing
Thing.
Preferably, described dermatological field antiseptic, algal polysaccharides, chitin are the reinforcing agent of the antiseptic
Component,
The total concentration of enhancer component relative to this antiseptic total concentration, by weight, 10:1 to 1:In the range of 300.
Preferably, described dermatological field antiseptic, the total concentration of contained enhancer component is anti-relative to this
The total concentration of microbial inoculum, by weight preferably 5:1 to 1:In the range of 100.
This antiseptic has that stability is good, usage amount is low, wide antibacterial bacterium spectrum, high-efficiency antimicrobial, the antibacterial effect duration
Long the advantages of, it is widely used in various daily life fields and medical domain.
Embodiment
A kind of dermatological field antiseptic that the present invention is provided, including hydrogen peroxide, ethanol, cocamidopropyl propyl amide sweet tea
Dish alkali, algal polysaccharides, chitin, polyethoxyolefin carboxyl guanidine, surfactant, the mass fraction of each component is：Hydrogen peroxide 2-5
Part, 2-3.8 parts of ethanol, 1.8-3 parts of Cocoamidopropyl betaine, 1.5-2.5 parts of algal polysaccharides, 2-2.5 parts of chitin, poly- second
2-2.5 parts of oxygen alkene carboxy guanidine, 1.5-3 parts of surfactant.
Preferably, described dermatological field antiseptic, the mass fraction of each component is：2 parts of hydrogen peroxide, second
2 parts of alcohol, 1.8 parts of Cocoamidopropyl betaine, 1.5 parts of algal polysaccharides, 2 parts of chitin, 2 parts of polyethoxyolefin carboxyl guanidine, surface
1.5 parts of activating agent.
Preferably, described dermatological field antiseptic, the surfactant is sulfonate, sulfate surface
Activating agent, phosphonate surfactant, phosphate surfactant active, the husky nurse of pool network, cationic surfactant or its mixing
Thing.
Preferably, described dermatological field antiseptic, algal polysaccharides, chitin are the reinforcing agent of the antiseptic
Component,
The total concentration of enhancer component relative to this antiseptic total concentration, by weight, 10:1 to 1:In the range of 300.
Preferably, described dermatological field antiseptic, the total concentration of contained enhancer component is anti-relative to this
The total concentration of microbial inoculum, by weight preferably 5:1 to 1:In the range of 100.
It is described above, it is only the preferred embodiments of the present invention, the limitation of other forms is not done to the present invention, appoints
What what those skilled in the art was changed or be modified as possibly also with the technology contents of the disclosure above to change on an equal basis etc.
Imitate embodiment.It is every without departing from the present invention program content, the technical spirit according to the present invention is to made for any of the above embodiments any
Simple modification, equivalent variations and remodeling, all fall within protection scope of the present invention.
Claims (5)
1. a kind of dermatological field antiseptic, including hydrogen peroxide, ethanol, Cocoamidopropyl betaine, algal polysaccharides,
Chitin, polyethoxyolefin carboxyl guanidine, surfactant, the mass fraction of each component is：2-5 parts of hydrogen peroxide, ethanol 2-3.8
Part, 1.8-3 parts of Cocoamidopropyl betaine, 1.5-2.5 parts of algal polysaccharides, 2-2.5 parts of chitin, polyethoxyolefin carboxyl guanidine 2-
2.5 parts, 1.5-3 parts of surfactant.
2. dermatological field antiseptic according to claim 1, the mass fraction of each component is：2 parts of hydrogen peroxide,
2 parts of ethanol, 1.8 parts of Cocoamidopropyl betaine, 1.5 parts of algal polysaccharides, 2 parts of chitin, 2 parts of polyethoxyolefin carboxyl guanidine, table
1.5 parts of face activating agent.
3. the dermatological field antiseptic according to claim 1-2, the surfactant is sulfonate, sulfate
Surfactant, phosphonate surfactant, phosphate surfactant active, the husky nurse of pool network, cationic surfactant or it is mixed
Compound.
4. dermatological field antiseptic according to claim 1, algal polysaccharides, chitin are the enhancing of the antiseptic
Agent component,
The total concentration of enhancer component relative to this antiseptic total concentration, by weight, 10:1 to 1:In the range of 300.
5. dermatological field antiseptic according to claim 4, the total concentration of contained enhancer component is relative to this
The total concentration of antiseptic, by weight preferably 5:1 to 1:In the range of 100.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710381475.3A CN107115356A (en) | 2017-05-25 | 2017-05-25 | A kind of dermatological field antiseptic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710381475.3A CN107115356A (en) | 2017-05-25 | 2017-05-25 | A kind of dermatological field antiseptic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107115356A true CN107115356A (en) | 2017-09-01 |
Family
ID=59728834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710381475.3A Pending CN107115356A (en) | 2017-05-25 | 2017-05-25 | A kind of dermatological field antiseptic |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107115356A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102908362A (en) * | 2004-09-07 | 2013-02-06 | 3M创新有限公司 | Antiseptic compositions and methods of use |
| CN103655314A (en) * | 2013-12-05 | 2014-03-26 | 青岛海芬海洋生物科技有限公司 | Moisturizing bath liquid containing sea biologically-active substances |
-
2017
- 2017-05-25 CN CN201710381475.3A patent/CN107115356A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102908362A (en) * | 2004-09-07 | 2013-02-06 | 3M创新有限公司 | Antiseptic compositions and methods of use |
| CN103655314A (en) * | 2013-12-05 | 2014-03-26 | 青岛海芬海洋生物科技有限公司 | Moisturizing bath liquid containing sea biologically-active substances |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2013299182B2 (en) | Physical antimicrobial method | |
| Najjar et al. | Prophylactic antibiotics and prevention of surgical site infections | |
| CN102387793B (en) | Antiseptic compositions comprising silver ions and menthol and uses thereof | |
| Bigliardi et al. | An Asian perspective on povidone iodine in wound healing | |
| CN102028705A (en) | Gynecologic article containing biological antifungal components | |
| Sadashivaiah et al. | Biofilms: their role in dermal fillers | |
| CN106236774A (en) | A kind of Multi-purpose antibiotic agent | |
| CN100379465C (en) | Inflammation-eliminating, pain-stopping, bacteria-resisting, pain-relieving soluble hemostatic gauze and its processing method | |
| CN106176603B (en) | A kind of plants essential oil micro emulsion gel and its preparation method and application | |
| CN101474284B (en) | External use medicament for treating fungal dermatopathy | |
| CN107279194A (en) | A kind of draft antiseptic | |
| US20110039906A1 (en) | Antibacterial combination therapy | |
| Hashmi et al. | The current state of topical burn treatments: a review | |
| CN107115356A (en) | A kind of dermatological field antiseptic | |
| KR20110096539A (en) | Intravascular indwelling catheter lock solution containing acetic acid and container containing the same | |
| CN107279187A (en) | A kind of Multi-purpose antibiotic agent | |
| CN107095901A (en) | A kind of antibacterial agent | |
| CN106177354A (en) | A kind of draft antibacterial | |
| CN106344605A (en) | Novel antibacterial agent | |
| CN106237335A (en) | A kind of dermatological field antibacterial | |
| EP3210619A2 (en) | Topical formulation for treating skin or mucosal infections, preparation method and uses thereof | |
| CN107213315A (en) | A kind of antibacterial agent | |
| Lipsky et al. | Topical antimicrobial agents for preventing and treating foot infections in people with diabetes | |
| Sabracos et al. | The in vitro effective antiviral action of povidone–iodine (PVP–I) may also have therapeutic potential by its intravenous administration diluted with Ringer’s solution | |
| CN107260930A (en) | A kind of draft antiseptic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170901 |